U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Content and Format of the Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Content and Format of the Dosage and Administration Section of Labeling for Human Prescription Drug and Biological Products March 2010

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-2007-D-0201
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research
Center for Biologics Evaluation and Research

This guidance is intended to help applicants draft the DOSAGE AND ADMINISTRATION section of labeling required by 21 CFR 201.57(c)(3). 
 

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2007-D-0201 .

Back to Top